Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt
By Emily Lever · October 10, 2024, 5:45 PM EDT
Vaccine developer Gritstone bio Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday with at least $100 million of debt, saying it was in discussions with a potential bidder...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login